Legis Daily

End Taxpayer Subsidies for Drug Ads Act

USA116th CongressHR-8399| House 
| Updated: 9/25/2020
Abby Finkenauer

Abby Finkenauer

Democratic Representative

Iowa

Cosponsors (2)
David J. Trone (Democratic)Elissa Slotkin (Democratic)

Ways and Means Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
End Taxpayer Subsidies for Drug Ads Act This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs. Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 10, 2019

Latest Companion Bill Action

S 116-73
Introduced in Senate
Sep 25, 2020
Introduced in House
Sep 25, 2020
Referred to the House Committee on Ways and Means.
  • January 10, 2019

    Latest Companion Bill Action

    S 116-73
    Introduced in Senate


  • September 25, 2020
    Introduced in House


  • September 25, 2020
    Referred to the House Committee on Ways and Means.

Taxation

Related Bills

  • S 116-1801: Affordable Medications Act
  • S 116-73: End Taxpayer Subsidies for Drug Ads Act
Business expensesIncome tax deductionsMarketing and advertisingPrescription drugs

End Taxpayer Subsidies for Drug Ads Act

USA116th CongressHR-8399| House 
| Updated: 9/25/2020
End Taxpayer Subsidies for Drug Ads Act This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs. Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 10, 2019

Latest Companion Bill Action

S 116-73
Introduced in Senate
Sep 25, 2020
Introduced in House
Sep 25, 2020
Referred to the House Committee on Ways and Means.
  • January 10, 2019

    Latest Companion Bill Action

    S 116-73
    Introduced in Senate


  • September 25, 2020
    Introduced in House


  • September 25, 2020
    Referred to the House Committee on Ways and Means.
Abby Finkenauer

Abby Finkenauer

Democratic Representative

Iowa

Cosponsors (2)
David J. Trone (Democratic)Elissa Slotkin (Democratic)

Ways and Means Committee

Taxation

Related Bills

  • S 116-1801: Affordable Medications Act
  • S 116-73: End Taxpayer Subsidies for Drug Ads Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business expensesIncome tax deductionsMarketing and advertisingPrescription drugs